Protara Therapeutics, Inc.
TARA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001359931
In the last 90 days, Protara Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 119 institutions reported holding it in 13F filings for Q2 2026, worth $176.0M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Protara Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- −4 vs. Q2 2021
- Shares held
- 6.31M
- −799.0K (−11.2%) vs. Q2 2021
- Total value
- $43.7M
- −$25.6M (−36.9%) vs. Q2 2021
- New holders
- 7
- 11 more added
- Sold out
- 11
- 10 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TARA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 119 | $176.0M |
| Q1 2026 | 114 | $237.4M |
| Q4 2025 | 105 | $212.3M |
| Q3 2025 | 81 | $114.0M |
| Q2 2025 | 76 | $90.1M |
| Q1 2025 | 59 | $123.8M |
| Q4 2024 | 60 | $156.6M |
| Q3 2024 | 35 | $19.1M |
| Q2 2024 | 38 | $22.2M |
| Q1 2024 | 34 | $18.3M |
| Q4 2023 | 30 | $8.17M |
| Q3 2023 | 31 | $8.55M |
| Q2 2023 | 29 | $12.3M |
| Q1 2023 | 29 | $16.9M |
| Q4 2022 | 30 | $14.7M |
| Q3 2022 | 31 | $16.7M |
| Q2 2022 | 33 | $18.4M |
| Q1 2022 | 35 | $33.2M |
| Q4 2021 | 38 | $46.5M |
| Q3 2021 | 36 | $43.7M |
| Q2 2021 | 40 | $69.3M |
| Q1 2021 | 50 | $134.0M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Protara Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Opaleye Management Inc. | 2,558,472 | $17.7M | 3.31% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 479,995 | $3.32M | 0.76% | −104,809−17.9% | Reduced |
| OrbiMed Advisors LLC | 450,000 | $3.11M | 0.03% | 00.0% | Unchanged |
| Vanguard Group Inc | 435,813 | $3.02M | 0.00% | −1,295−0.3% | Reduced |
| Perceptive Advisors LLC | 421,641 | $2.92M | 0.04% | 00.0% | Unchanged |
| Citadel Advisors LLC | 346,431 | $2.40M | 0.00% | +4,410+1.3% | Added |
| Boxer Capital, LLC | 209,227 | $1.45M | 0.05% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 199,671 | $1.38M | 0.01% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 168,818 | $1.17M | 0.00% | +110,500+189.5% | Added |
| Goldman Sachs Group Inc | 155,973 | $1.08M | 0.00% | +23,716+17.9% | Added |
| Two Sigma Investments, LP | 130,935 | $906.0K | 0.00% | +75,530+136.3% | Added |
| Renaissance Technologies LLC | 115,900 | $802.0K | 0.00% | +64,473+125.4% | Added |
| Bridgeway Capital Management, LLC | 112,500 | $779.0K | 0.01% | +112,500 | New |
| Millennium Management LLC | 104,918 | $726.0K | 0.00% | −24,462−18.9% | Reduced |
| Geode Capital Management, LLC | 79,017 | $546.0K | 0.00% | −3,968−4.8% | Reduced |
| Boothbay Fund Management, LLC | 47,423 | $328.0K | 0.01% | −9,460−16.6% | Reduced |
| BlackRock Inc. | 44,036 | $306.0K | 0.00% | +3,911+9.7% | Added |
| Knott David M | 36,479 | $252.0K | 0.11% | +315+0.9% | Added |
| Morgan Stanley | 26,582 | $184.0K | 0.00% | −22,302−45.6% | Reduced |
| Schonfeld Strategic Advisors LLC | 23,955 | $166.0K | 0.00% | −500−2.0% | Reduced |
| State Street Corp | 22,800 | $158.0K | 0.00% | +12,441+120.1% | Added |
| Northern Trust Corp | 22,279 | $154.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 17,907 | $124.0K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 17,130 | $119.0K | 0.01% | +17,130 | New |
| Susquehanna International Group, LLP | 15,893 | $110.0K | 0.00% | −4,716−22.9% | Reduced |
| Marshall Wace, LLP | 15,190 | $105.0K | 0.00% | −2,279−13.0% | Reduced |
| Jump Financial, LLC | 14,500 | $100.0K | 0.01% | +14,500 | New |
| Prelude Capital Management, LLC | 13,155 | $91.0K | 0.00% | +1,455+12.4% | Added |
| Trexquant Investment LP | 12,454 | $86.0K | 0.01% | +12,454 | New |
| JPMorgan Chase & Co | 8,040 | $56.0K | 0.00% | +7,863+4,442.4% | Added |
| Advisor Group Holdings, Inc. | 2,600 | $18.0K | 0.00% | +2,600 | New |
| Simplex Trading, LLC | 581 | $5.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 664 | $4.00K | 0.00% | +664 | New |
| Bank of America Corp | 522 | $3.00K | 0.00% | −410−44.0% | Reduced |
| Wells Fargo & Company | 560 | $3.00K | 0.00% | +1+0.2% | Added |
| American Portfolios Advisors | 100 | $692 | 0.00% | +100 | New |
| Rock Springs Capital Management LP | 0 | $0 | 0.00% | −693,542−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −350,010−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −17,700−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −13,678−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −12,151−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,548−100.0% | Sold out |
| Retirement Group, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −55−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −99−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −29−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −15−100.0% | Sold out |